Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.
Cantor L B, Hoop J, Morgan L, Wudunn D, Catoira Y
This study found bimatoprost lowered IOP more than travoprost in glaucoma/ocular hypertension patients, suggesting bimatoprost may offer slightly superior pressure control.